etoposide has been researched along with clerocidin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomi, K; Iwasaki, T; Kawada, SZ; Nakano, H; Takiguchi, T; Uosaki, Y; Yamashita, Y | 1 |
| Nakano, H | 1 |
| Fujii, N; Kawada, S; Nakano, H; Yamashita, Y | 1 |
| Jensen, PB; Sehested, M | 1 |
1 review(s) available for etoposide and clerocidin
| Article | Year |
|---|---|
[Antitumor agents targeting mammalian topoisomerases].
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Diterpenes; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Leukemia P388; Mice | 1991 |
3 other study(ies) available for etoposide and clerocidin
| Article | Year |
|---|---|
UCT4B, a new antitumor antibiotic with topoisomerase II mediated DNA cleavage activity, from Streptomyces sp.
Topics: Antibiotics, Antineoplastic; Bacteria; Diterpenes; DNA Topoisomerases, Type II; Etoposide; Microbial Sensitivity Tests; Streptomyces | 1992 |
Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin.
Topics: Anti-Bacterial Agents; Diterpenes; DNA; DNA Topoisomerases, Type II; Enzyme Induction; Etoposide; Hot Temperature; Teniposide | 1991 |
Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle.
Topics: Aclarubicin; Blotting, Western; Diterpenes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Razoxane; Tumor Cells, Cultured | 1996 |